CIK 0001842952 · <br>Emerging growth company
Context Therapeutics Inc.
Sign in to watch- Ticker
- CNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863738787
- Phone
- 267-225-7416
- Business address
- 2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103
- Former names
- Context Therapeutics LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-13 | Minai-Azary Jennifer Lynn Chief Financial Officer | Grant or award · Stock Option (right to buy) | +371,800 | 371,800 | ||
| 2025-02-13 | Levit Alex C. Chief Legal Officer, Corp. Sec | Grant or award · Stock Option (right to buy) | +349,900 | 349,900 | ||
| 2025-02-13 | Dansky Ullmann Claudio Chief Medical Officer | Grant or award · Stock Option (right to buy) | +174,960 | 174,960 | ||
| 2025-02-13 | Lehr Martin A. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +802,700 | 802,700 | ||
| 2025-01-13 | Pasternak Andy Director | Grant or award · Stock Option (right to buy) | +20,685 | 20,685 | ||
| 2024-09-04 | Smith Karen L. Director | Grant or award · Stock Option (right to buy) | +19,315 | 19,315 | ||
| 2024-09-04 | Walker Luke Nathaniel Director | Grant or award · Stock Option (right to buy) | +19,315 | 19,315 | ||
| 2024-08-01 | Dansky Ullmann Claudio Chief Medical Officer | Grant or award · Stock Option (right to buy) | +202,170 | 202,170 | ||
| 2024-06-13 | Stacey Jennifer Evans Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2024-06-13 | Kantoff Philip W. Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2024-06-13 | West Linda Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2024-06-13 | BERMAN RICHARD J Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2024-03-21 | Minai-Azary Jennifer Lynn Chief Financial Officer | Grant or award · Stock Option (right to buy) | +160,115 | 160,115 | ||
| 2024-03-21 | Levit Alex C. Chief Legal Officer, Corp. Sec | Grant or award · Stock Option (right to buy) | +153,515 | 153,515 | ||
| 2024-03-21 | Lehr Martin A. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +291,402 | 291,402 | ||
| 2023-05-31 | Kantoff Philip W. Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-05-31 | West Linda Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-05-31 | Stacey Jennifer Evans Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-05-31 | BERMAN RICHARD J Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2023-02-21 | Lehr Martin A. Chief Executive Officer | Purchase | +5,823 | $0.84 | $5K | 159,701 |
Page 2 of 5 · 85 trades